GSK Investigational Site

Eau Claire, Wisconsin 54701

0 studies enrolling now · 2 studies all time

What they study most

Herpes Zoster, Neoplasms, Breast

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier — Completed
• Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed